Glenn Hassan is the founder of CANbridge Pharmaceuticals. CANbridge Pharmaceuticals has raised $224M in total funding.
Glenn Hassan is the Chief Financial Officer at CANbridge Pharmaceuticals. He has a background in banking and investment within the healthcare and global therapeutics sector. Before joining CANbridge, he held roles at China Renaissance Capital, Leerink Capital Partners, Citadel LLC (Surveyor Capital), and Fidelity Investments.
Full founder directory · Investor directory · Company funding database · Fundraising library